FTB Advisors Inc. grew its holdings in shares of Monsanto Company (NYSE:MON) by 35.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,265 shares of the basic materials company’s stock after purchasing an additional 850 shares during the period. FTB Advisors Inc.’s holdings in Monsanto were worth $391,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MON. Meyer Handelman Co. grew its holdings in shares of Monsanto by 0.6% in the 3rd quarter. Meyer Handelman Co. now owns 124,552 shares of the basic materials company’s stock worth $14,923,000 after acquiring an additional 706 shares during the period. Toronto Dominion Bank grew its holdings in shares of Monsanto by 6.3% in the 3rd quarter. Toronto Dominion Bank now owns 1,014,313 shares of the basic materials company’s stock worth $121,519,000 after acquiring an additional 59,750 shares during the period. Nikko Asset Management Americas Inc. grew its holdings in shares of Monsanto by 1.3% in the 2nd quarter. Nikko Asset Management Americas Inc. now owns 450,700 shares of the basic materials company’s stock worth $53,345,000 after acquiring an additional 5,700 shares during the period. Oakbrook Investments LLC grew its holdings in shares of Monsanto by 7.4% in the 3rd quarter. Oakbrook Investments LLC now owns 20,350 shares of the basic materials company’s stock worth $2,438,000 after acquiring an additional 1,400 shares during the period. Finally, Aviva PLC grew its holdings in shares of Monsanto by 1.2% in the 2nd quarter. Aviva PLC now owns 304,501 shares of the basic materials company’s stock worth $36,052,000 after acquiring an additional 3,569 shares during the period. Institutional investors own 74.98% of the company’s stock.
In other Monsanto news, VP Duraiswami Narain sold 2,860 shares of the stock in a transaction on Monday, September 25th. The stock was sold at an average price of $120.00, for a total transaction of $343,200.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Nicole M. Ringenberg sold 7,890 shares of the stock in a transaction on Monday, October 16th. The shares were sold at an average price of $122.25, for a total value of $964,552.50. Following the sale, the vice president now owns 38,600 shares in the company, valued at approximately $4,718,850. The disclosure for this sale can be found here. In the last quarter, insiders have sold 49,236 shares of company stock worth $5,931,934. 0.79% of the stock is owned by insiders.
A number of equities research analysts recently weighed in on the company. BMO Capital Markets restated a “buy” rating and issued a $128.00 price target on shares of Monsanto in a report on Thursday, October 5th. Barclays PLC restated an “equal weight” rating and issued a $124.00 price target (up previously from $120.00) on shares of Monsanto in a report on Thursday, October 5th. Macquarie cut Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Wells Fargo & Company upped their price target on Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a report on Tuesday, October 10th. Finally, Jefferies Group LLC restated a “hold” rating and issued a $128.00 price target on shares of Monsanto in a report on Friday, September 15th. Eleven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $124.61.
Shares of Monsanto Company (NYSE:MON) traded down $0.09 during trading hours on Monday, reaching $118.13. The company’s stock had a trading volume of 1,054,200 shares, compared to its average volume of 1,937,693. The firm has a market cap of $52,000.00, a PE ratio of 21.36, a PEG ratio of 1.70 and a beta of 1.05. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12. Monsanto Company has a 52-week low of $101.52 and a 52-week high of $122.79.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.61. The firm had revenue of $2.69 billion for the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. Monsanto’s quarterly revenue was up 4.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.07 EPS. equities analysts anticipate that Monsanto Company will post 5.74 EPS for the current year.
WARNING: This piece was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at https://transcriptdaily.com/2017/11/27/monsanto-company-mon-holdings-boosted-by-ftb-advisors-inc.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.